This bill adds a new subchapter to chapter 131 of title 5 that imposes new limits on how Members of Congress and certain family members may hold and trade securities. It treats spouses and dependent children as covered individuals for many purposes, defines covered investments broadly to include derivatives, and gives supervising ethics offices new enforcement tools.
Why it matters: the measure aims to remove perceived conflicts and insider-trading risk by changing what lawmakers (and their immediate families) may buy and how sales are disclosed and penalized. If enacted, congressional offices will need new compliance processes, and supervising ethics offices will acquire concrete financial remedies and reporting duties not currently found in chapter 131.
At a Glance
What It Does
The bill prohibits covered individuals from purchasing ‘‘covered investments’’ while serving and requires Members to publicly file a notice 7–14 calendar days before any intended sale of such assets. It defines covered investments to include securities of issuers with registered classes and synthetic exposures like options and warrants, while carving out specific fund and trust situations.
Who It Affects
Directly affects Members of Congress (including Delegates and the Resident Commissioner), their spouses, and dependent children; congressional ethics offices and the Clerk/Secretary offices that must accept and publish sale notices; and market intermediaries that execute or advise on transactions for covered individuals.
Why It Matters
The statute creates an affirmative public-notice regime and a civil fee-and-remedy structure (including forced divestiture) that shifts enforcement away from purely criminal or FEC frameworks and toward internal congressional ethics enforcement, changing compliance incentives and disclosure timelines for congressional trading.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Act inserts a new subchapter into the ethics chapter of title 5 and builds a compact set of rules around who is covered, what counts as a covered investment, and how violations are handled. It treats a ‘‘covered individual’’ as a Member of Congress plus that Member’s spouse and dependent children. ‘‘Covered investment’’ is deliberately broad: it includes securities of issuers with registered classes under the Exchange Act and ‘‘synthetic’’ economic interests—derivatives, options, warrants, and similar instruments.
The statute nonetheless excludes some vehicles: excepted investment funds, interests in small businesses, and trusts where the covered individual lacks control over the trustee and the trustee is not a close family member.
The operational core of the bill is twofold. First, it bars purchases of covered investments by covered individuals during their federal service.
Second, it creates a mandatory advance-sale notice: a Member must file a notice describing the intended sale, the projected date, and number of shares, and that notice must be made public on the House or Senate website at least seven calendar days and at most fourteen calendar days before the sale. The notice may be withdrawn before the end of that window if the sale is called off.
Members must file notices for intended sales by themselves and for trades by spouses or dependent children.Enforcement is administered by the ‘‘supervising ethics office’’ (the office that already handles ethics matters for that chamber). When a violation is found, the office can require payment of a fee and, for purchases made in violation of the purchase ban, compel sale of the offending asset.
The fee is numerical and formulaic: the greater of $2,000 or 10% of the transaction value, plus any net gain realized from the asset during the Member’s time as a covered individual. The bill also prohibits payment of assessed fees from Members’ representational allowances, Senators’ official expense accounts, or campaign contributions, requires fee receipts to be deposited into the Treasury, allows referral to DOJ if a Member resigns or retires rather than pay, and authorizes supervising ethics offices to issue interpretive guidance and weigh aggravating or mitigating facts.A small-but-important implementation detail: the statute becomes effective 180 days after enactment, giving Clerk/Secretary offices and supervising ethics offices time to build filing and public-disclosure systems and to draft guidance defining technical terms such as ‘‘comparable economic interest’’ and the treatment of concentrated funds.
The Five Things You Need to Know
The statute treats a Member’s spouse and dependent children as covered individuals for the prohibition and notice rules, expanding coverage beyond just the officeholder.
Covered investments include securities of issuers with Exchange Act-registered classes and synthetic exposures (options, warrants, and similar derivatives).
Members must file and publish a notice of intent to sell covered investments between 7 and 14 calendar days before the sale; the notice must list projected date, description, and number of shares and can be withdrawn before the window expires.
A supervising ethics office can impose a fee equal to the greater of $2,000 or 10% of the violating transaction plus any net gain realized while the individual was a covered individual.
Members may not pay assessed fees from their Members’ Representational Allowance, Senators’ official accounts, or campaign contributions; supervising ethics offices can refer nonpayment after resignation to the Department of Justice.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Designates the Act as the "Stop Insider Trading Act." This is the organizational header and has no operational effect, but signals congressional intent and is the reference name for implementing guidance and rulemaking by clerk/secretary offices.
Table of contents addition
Adds a new Subchapter IV to chapter 131 and lists three new statutory headings (definitions, restrictions, enforcement). Practically, this change places the new rules inside the existing ethics chapter so supervising ethics offices and congressional officers will apply existing administrative authorities and procedures to the new provisions.
Definitions (who and what is covered)
Defines 'covered individual' to include Members, spouses, and dependent children and defines 'covered investment' broadly to reach exchange-registered securities and synthetic instruments. It also creates exclusions: certain excepted investment funds, concentrated U.S. or home-state funds that otherwise would qualify as excepted, small-business interests under the Small Business Act, and trusts where the covered individual lacks trustee control and the trustee is not a close family member. Those exclusions matter operationally because they create predictable carve-outs that compliance programs must code into screening and reporting systems.
Transaction rules (purchase ban and sale notice)
Establishes the operative prohibitions and the public-notice regime: covered individuals may not purchase covered investments while serving; sales are allowed but must be preceded by a filed and publicly posted notice 7–14 days in advance that includes projected date, description, and share count. The filing must go to the Clerk of the House or the Secretary of the Senate depending on chamber, and the Clerk/Secretary must publish the filing and any withdrawal on a website. The statute also preserves narrow exceptions for occupational transactions by spouses/dependents and reinvestment of dividends.
Enforcement mechanics and penalties
Gives supervising ethics offices the authority to calculate and assess civil fees—$2,000 or 10% of the violating transaction value (whichever is greater) plus net gains realized since becoming covered—and to require divestiture for purchase violations. It forbids use of Members’ official allowances or campaign contributions to pay assessed fees, requires deposit of collected fees to the Treasury as miscellaneous receipts, allows referral to DOJ if a Member resigns or retires instead of paying, and authorizes issuance of interpretive guidance. Those enforcement mechanics are administrative and civil; the bill does not create a new criminal statute but increases civil penalties and administrative remedies available to ethics offices.
Timing for implementation
The amendments take effect 180 days after enactment. That 180-day window is the only timing mechanism; compliance offices and Members will need to use that period to adopt internal rules, publish filing portals, and issue interpretive guidance to operationalize the definitions and notice process.
This bill is one of many.
Codify tracks hundreds of bills on Government across all five countries.
Explore Government in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Ethics oversight offices: supervising ethics offices gain explicit statutory authority to assess fees, compel divestiture, publish notices, and issue interpretive guidance—giving them sharper tools to enforce trading rules.
- Public and market-watchdog organizations: the public notice requirement and online publication create a predictable, searchable trail of planned sales that improves transparency and helps investigators and journalists detect suspicious timing or patterns.
- Retail investors and market integrity advocates: by widening the statutory reach to synthetic exposures and by forbidding purchases during service, the bill reduces specific pathways for opportunity-based conflicts and reinforces parity between lawmakers and ordinary investors.
Who Bears the Cost
- Members of Congress and their immediate families: they must change portfolio construction, stop new purchases of covered investments while serving, file advance-sale notices, and face potentially substantial civil fees and forced sales.
- Clerk of the House/Secretary of the Senate and congressional ethics staffs: they must build or expand intake, publication, and case-management systems, handle compliance reviews and appeals, and draft interpretive guidance—work that requires staff time and likely additional funding.
- Financial advisors and broker-dealers: they will need enhanced onboarding and surveillance for accounts tied to Members/spouses/dependents, add pre-trade restrictions, and counsel clients about the advance-notice window and divestiture risks, increasing compliance and advisory burdens.
Key Issues
The Core Tension
The Act pits two legitimate objectives against one another: reducing actual and perceived insider trading by restricting lawmakers’ market activity versus preserving Members’ ability to manage private wealth, minimize financial harms, and maintain privacy. Strong, automatic rules deter abuse and simplify enforcement but can be blunt—causing forced sales, administrative burdens, and workarounds—while narrowly tailored rules avoid overbreadth but risk leaving enforcement gaps and loopholes that undermine public confidence.
The statute sets a clear policy goal—reduce opportunities for insider trading by public officers—while leaving significant implementation work to supervising ethics offices and the Clerk/Secretary. Key ambiguities will require administrative clarification: what precisely counts as a 'comparable economic interest' when new derivative products emerge; how 'net gain realized' is calculated for complex option strategies; and how trusts with partial retained influence should be treated.
Those definitional questions will shape practical compliance obligations and may produce litigation if guidance is perceived as overbroad.
The enforcement design mixes a civil formulaic fee with compelled divestiture and public naming of intended sales. That combination raises procedural and fairness questions: the bill provides little in the text about appeal procedures or timing between assessment and compelled sale; supervising ethics offices will need to establish notice-and-comment-like procedures or internal adjudication to avoid due-process claims.
The statute's exceptions (occupational transactions for spouses; reinvested dividends; small-business interests; certain funds and trusts) are helpful but also create loopholes that sophisticated actors could exploit if guidance is not tightly written. Finally, forbidding payment of fees from official allowances and campaign coffers avoids obvious pay-to-escape risks but pushes financial responsibility onto the individual and could prompt resignation-and-referral dynamics the bill anticipates with DOJ referral authority.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.